(Q33980954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

title

Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

Wei-Min Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yang Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xin-Rong Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yao-Hui Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hai-Xiang Sun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jia Fan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary & Pancreatic Diseases International

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

346-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Hepatocellular carcinoma: present status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

A decade's studies on metastasis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

The relation of type 2 diabetes and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Role of diabetes mellitus in the etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Bias in location and selection of studies

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Estimation of risk of major complications after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Effect of diabetes mellitus on hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

The level of fasting serum insulin, but not adiponectin, is associated with the prognosis of early stage hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Diabetes and hepatocellular carcinoma: associations, biologic plausibility, and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Metabolic and nutritional considerations in nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

Metformin and reduced risk of cancer in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2811%2960059-3

7 January 2021

10.1016/S1499-3872(11)60059-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813381%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference